loader
Please Wait
Applying Filters...

EuroAPI Header EuroAPI Header

X
menu

    Market Place

    Market Place

    Post Enquiry

    Post Enquiry
    menu

    List of Certificates of Suitability (CEPs) for cep_2022_379___rev_00 Active Pharmaceutical Ingredient (API) issued by the EDQM. Original Data: EDQM Database

    Client Virtual Booth
    Menu

    Extrovis AG

    EVENTS

    • Webinars & Exhibitions

    PRESENTATION(s)

    VIDEO(s)

    DIGITAL CONTENT

    APIs // Active Pharmaceutical Ingredients

    DEVELOPMENTS

    DOSSIERs // Finished Dosage Forms

    SERVICES

    PharmaCompass

    With Fermion, start the journey of your innovative API.

    Send me more info on How To Grow My Business Digitally?

    Left Arrow
    Right Arrow
    Filters Filter
    Cross PopUp
    FILTER :

    filter

    01 EXTROVIS AG Baar CH (1)

    filter

    01 Dapsone (1)

    filter

    01 Switzerland (1)

    filter

    01 Valid (1)

    ListList of Suppliers
    refresh Reset Filter
    refresh Reset Filter
    product-page Supplier Virtual Booth
    price-trend Ask Us

    EXTROVIS AG Baar CH

    Contact Supplier
      Virtual Booth Upload your Marketing & Sales content on your company Virtual Booth, click HERE
      Post an Enquiry Post an Enquiry
      Flag Switzerland
      Virtual Booth Virtual Booth
      Digital Content Digital Content

      Dapsone

      PDF Supplier PDF
      URL Supplier Web Content
      CEP 2022-379 - Rev 00
      Valid
      Chemical
      2024-06-12
      77
      ASK
      US
      PHARMACOMPASS
      Upload
      your Marketing & Sales content

      Looking for Certificates of Suitability (CEPs) for CEP 2022-379 - Rev 00 of Extrovis Ag Baar Ch

      Looking for Certificates of Suitability (CEPs) for CEP 2022-379 - Rev 00 of Extrovis Ag Baar Ch 1

      20

      Extrovis Ag Baar Ch, based in Switzerland, is a pharmaceutical company.

      They are recognized for Extrovis's success lies in improving healthcare through innovation.

      One of their significant offerings is Dapsone, supported by a 'Valid' Certificate of Suitability (CEP) with the number CEP 2022-379 - Rev 00

      This Chemical Type CEP, issued on June 12, 2024, remains in force until January 01, 1970, ensuring its reliability within the pharmaceutical industry.

      Substance Number 77 associated with this CEP further emphasizes

      Post Enquiry
      POST ENQUIRY